Hepion Pharmaceuticals, Inc. (HEPA) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 27, 2026.
- Filings shown
- 23
- Open-market buys
- 7
- Open-market sells
- 0
- Buys, 10b5-1 box not checked
- 7 of 7
Counts cover the 23 most recent Form 4 filings Tradune holds for HEPA (filed Aug 12 – Oct 27, 2026); the score below covers only the trailing 90 days (0 buys, 0 sells). SEC EDGAR Form 4 filings for HEPA last checked Nov 21, 2026, 09:00 UTC; the latest HEPA filing Tradune holds was filed Oct 27, 2026. This is not guaranteed to be the complete record — see HEPA's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for HEPA filed Sep 10 – Oct 27, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Danina FisherDirector | 1 | 0 | 200,000 | — | +$10,000 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at HEPA
Insiders reported 7 open-market purchases of HEPA between Aug 12, 2026 and Oct 27, 2026, across 6 distinct buyers. The most recent purchase was reported by Danina Fisher (Director) on Sep 29, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 510,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 510,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,530,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,530,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 510,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,530,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,530,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 510,000 | — | — | — | Oct 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Derivative purchase Warrants | 200,000 | — | — | — | Sep 29, 2026 |
| Open-market purchase 10b5-1 box not checked | 200,000 | $0.05 | 200,000 | — | Sep 29, 2026 |
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Derivative purchase Warrants | 12,500,000 | — | — | — | Sep 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 299,000 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,345,500 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,345,500 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,345,500 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 299,000 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 299,000 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 1,345,500 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Stock Options | 299,000 | — | — | — | Aug 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 500,000 | $0.05 | 500,000 | — | Aug 3, 2026 |
| Derivative purchase Warrants | 500,000 | — | — | — | Aug 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,000,000 | $0.05 | 3,250,000 | +160% | Aug 3, 2026 |
| Derivative purchase Warrants | 2,000,000 | — | — | — | Aug 3, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,000,000 | $0.05 | 3,250,000 | +160% | Aug 3, 2026 |
| Derivative purchase Warrants | 2,000,000 | — | — | — | Aug 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,000,000 | $0.05 | 3,250,000 | +160% | Aug 3, 2026 |
| Derivative purchase Warrants | 2,000,000 | — | — | — | Aug 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 2,000,000 | $0.05 | 16,250,000 (indirect) | +14% | Aug 3, 2026 |
| Open-market purchase 10b5-1 box not checked | 8,000,000 | $0.05 | 14,250,000 (indirect) | +128% | Aug 3, 2026 |
| Derivative purchase Warrants | 8,000,000 | — | — | — | Aug 3, 2026 |
| Derivative purchase Warrants | 2,000,000 | — | — | — | Aug 3, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to HEPA's (Oct 27, 2026).
Frequently asked about HEPA insider activity
How many insiders bought HEPA stock in these Form 4 filings?
6 distinct insiders at Hepion Pharmaceuticals, Inc. reported 7 open-market purchases (Form 4 code P) of HEPA shares between Aug 12, 2026 and Oct 27, 2026, the most recent filed by Danina Fisher (Director) on Sep 29, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for HEPA?
The most recent Form 4 on this page was filed by Gary S. Stetz II (Director) on Oct 27, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market HEPA insider purchase shown?
The largest open-market purchase among the filings shown was 8,000,000 HEPA shares at $0.05 (about $400,000) by Vincent S. LoPriore (Executive Chairman) on Aug 3, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent HEPA insider purchases have the Form 4 10b5-1 box checked?
No. All 7 HEPA open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Danina Fisher (Director) on Sep 29, 2026, 200,000 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for HEPA — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.